510 related articles for article (PubMed ID: 31112804)
1. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
[TBL] [Abstract][Full Text] [Related]
2. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
[TBL] [Abstract][Full Text] [Related]
3. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
Yang S; Xu H; Sun J; Sun S
Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
Tian L; Sun Z; Zhang Z
BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
[TBL] [Abstract][Full Text] [Related]
5. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.
Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087
[TBL] [Abstract][Full Text] [Related]
6. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
7. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
Zhang F; Li Y; Lv Y; Zheng B; Xue F
J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
[TBL] [Abstract][Full Text] [Related]
9. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India.
Kharat AS; Makwana N; Nasser M; Gayen S; Yadav B; Kumar D; Veeraraghavan B; Mercier C
Int J Antimicrob Agents; 2024 May; 63(5):107125. PubMed ID: 38431109
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
[TBL] [Abstract][Full Text] [Related]
11. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Hwang H; Kim B
Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
[TBL] [Abstract][Full Text] [Related]
13. Direct detection of ESKAPEc pathogens from whole blood using the T2Bacteria Panel allows early antimicrobial stewardship intervention in patients with sepsis.
Drevinek P; Hurych J; Antuskova M; Tkadlec J; Berousek J; Prikrylova Z; Bures J; Vajter J; Soucek M; Masopust J; Martinkova V; Adamkova J; Hysperska V; Bebrova E
Microbiologyopen; 2021 Jun; 10(3):e1210. PubMed ID: 34180598
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
15. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
16. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
[TBL] [Abstract][Full Text] [Related]
17. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
[TBL] [Abstract][Full Text] [Related]
18. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
19. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
Cohen B; Liu J; Larson E
J Prev Med Hyg; 2017 Dec; 58(4):E294-E301. PubMed ID: 29707660
[TBL] [Abstract][Full Text] [Related]
20. Distribution of Antimicrobial Resistance and Virulence Genes within the Prophage-Associated Regions in Nosocomial Pathogens.
Kondo K; Kawano M; Sugai M
mSphere; 2021 Aug; 6(4):e0045221. PubMed ID: 34232073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
